Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy
4/18/2013 7:56:51 AM
More...
|
Celltrion, Inc.: Successful Development of Broad Spectrum Human Monoclonal Antibodies Against Major Influenza Viruses (H1N1 and H5N1)
3/9/2010 11:35:13 AM
More...
|
Hospira, Inc. (HSP) (JOBS) in Deal with Celltrion, Inc. on Biogenerics
10/9/2009 6:48:11 AM
More...
|
Hospira, Inc. (HSP), Celltrion, Inc. Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
10/8/2009 11:15:41 AM
More...
|
Celltrion, Inc. and CSL Limited (CMXHF.PK) Announce Collaboration to Develop and Manufacture Monoclonal Antibody
1/10/2008 6:48:09 AM
More...
|
FDA Approves Celltrion, Inc. to Manufacture ORENCIA(R) (abatacept)
12/18/2007 7:08:29 AM
More...
|
VaxGen, Inc. (VXGN) Raises $51.3 Million Through Sale Of Interest In Celltrion, Inc.
1/3/2007 2:33:47 PM
More...
|
A&G Pharmaceutical, Inc. And Celltrion, Inc. Announce Bioprocess Development & Manufacturing Agreement For A&G Anti-GP88 Cancer Therapeutic Antibody - Deal Worth Up To $8.4 Million
6/7/2006 10:45:33 AM
More...
|
VaxGen, Inc. (VXGN) Advances Toward Filing Its Financial Statements As Celltrion, Inc. Completes Preparation Of U.S. GAAP Financial Statements
1/25/2006 10:31:05 AM
More...
|
Aphton Corporation (APHT) Announces Closing of Commercialization and Manufacturing Agreements for IGN311 With Celltrion, Inc.
11/17/2005 12:01:42 PM
More...
|
|